Speedel News
Most Popular Speedel Story
Novartis buying Speedel for $880 million
Switzerland's Novartis has scooped up a majority of the shares of Speedel and plans to swiftly complete the purchase of all its stock in a deal valued at $880 million. At 130 francs per share,... Read more...
Latest Headlines
- July 10, 2008
- April 23, 2008
- September 19, 2007
- December 19, 2006
- June 12, 2006
- May 16, 2006
- August 10, 2005
- August 3, 2005
- July 20, 2005
- July 6, 2005
Paid Research Reports
- RNA therapy: the next big thing after monoclonal antibodies?
- Biotech M&A Strategies: Deal assessments, trends and future prospects
- The Dermatology Market Outlook to 2013: Competitive landscape, pipeline analysis and growth opportunities
- Pipeline Insight: Cancer Overview - Breast, Gynecological, Genitourinary - Diverse drugs approaching the market for many tumor t
- Sales Force Effectiveness
